CATALIOTTI, ALESSANDRO
CATALIOTTI, ALESSANDRO
SCIENZE MEDICHE E PEDIATRICHE (attivo dal 01/01/1990 al 30/10/2014)
HYPEROMOCISTEINEMIA PREDICTS CARDIOVASCULAR OUTCOMES IN HEMODIALYSIS PATIENTS
2002-01-01 Mallamaci, F.; Zoccali, C.; Tripepi, G.; Fermo, I.; Benedetto, F. A.; Cataliotti, A.; Bellanuova, I.; Malatino, L. S.; SOLDARINI AND CREED INVESTIGATORS, A.; Fatuzzo, P.; Rapisarda, F.
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease
2003-01-01 Zoccali, C.; Mallamaci, F.; Tripepi, G.; Parlongo, S; Cutrupi, S.; Bonanno, G.; Rapisarda, F; Fatuzzo, P.; Seminara, G.; Cataliotti, A.; Malatino, L. S.
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease
2002-01-01 Zoccali, C; Mallamaci, F; Tripepi, G; Parlongo, S; Cutrupi, S; Benedetto, Fa; Cataliotti, A; Malatino, L; on Behalf of the Creed, Investigator; Rapisarda, F.; Fatuzzo, P.
PLASMA CONCENTRATION OF ASYMMETRICAL DYMETHYLARGININE AND MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE: “A PROSPECTIVE STUDY” .
2001-01-01 Zoccali, Carmine; Bode-Böger, Stefanie M.; Mallamaci, Francesca; Benedetto, Frank Antonio; Tripepi, Giovanni; Malatino, Lorenzo; Cataliotti, Alessandro; Bellanuova, Ignazio; Fermo, Isabella; Frölich, Jürgen C.; Böger, Rainer H.; Enia, Giuseppe; Parlongo, Saverio; Cutrupi, Sebastiano; Tripepi, Rocco; Panuccio, Vincenzo; Marino, Carmela; Rapisarda, Francesco; Fatuzzo, Pasquale; Bonanno, Grazia; Seminara, Giuseppe; Stancanelli, Benedetta; Candela, Vincenzo; Labate, Carlo; Tassone, Filippo
Soluble E-selectina is an marker of outcome in end renal disease and interacts with inflammation to determine cardiovascular risk
file da validare2007-01-01 Malatino, L; Stancanelli, B; Cataliotti, A; Fatuzzo, P; Rapisarda, F; Bonanno, G; Bellanuova, I; Seminara, G; Leonardis, D; Tripepi, G.; Mallaci, F.; Zoccali, C.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
HYPEROMOCISTEINEMIA PREDICTS CARDIOVASCULAR OUTCOMES IN HEMODIALYSIS PATIENTS | 1-gen-2002 | Mallamaci, F.; Zoccali, C.; Tripepi, G.; Fermo, I.; Benedetto, F. A.; Cataliotti, A.; Bellanuova, I.; Malatino, L. S.; SOLDARINI AND CREED INVESTIGATORS, A.; Fatuzzo, P.; Rapisarda, F. | |
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease | 1-gen-2003 | Zoccali, C.; Mallamaci, F.; Tripepi, G.; Parlongo, S; Cutrupi, S.; Bonanno, G.; Rapisarda, F; Fatuzzo, P.; Seminara, G.; Cataliotti, A.; Malatino, L. S. | |
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease | 1-gen-2002 | Zoccali, C; Mallamaci, F; Tripepi, G; Parlongo, S; Cutrupi, S; Benedetto, Fa; Cataliotti, A; Malatino, L; on Behalf of the Creed, Investigator; Rapisarda, F.; Fatuzzo, P. | |
PLASMA CONCENTRATION OF ASYMMETRICAL DYMETHYLARGININE AND MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE: “A PROSPECTIVE STUDY” . | 1-gen-2001 | Zoccali, Carmine; Bode-Böger, Stefanie M.; Mallamaci, Francesca; Benedetto, Frank Antonio; Tripepi, Giovanni; Malatino, Lorenzo; Cataliotti, Alessandro; Bellanuova, Ignazio; Fermo, Isabella; Frölich, Jürgen C.; Böger, Rainer H.; Enia, Giuseppe; Parlongo, Saverio; Cutrupi, Sebastiano; Tripepi, Rocco; Panuccio, Vincenzo; Marino, Carmela; Rapisarda, Francesco; Fatuzzo, Pasquale; Bonanno, Grazia; Seminara, Giuseppe; Stancanelli, Benedetta; Candela, Vincenzo; Labate, Carlo; Tassone, Filippo | |
Soluble E-selectina is an marker of outcome in end renal disease and interacts with inflammation to determine cardiovascular risk | 1-gen-2007 | Malatino, L; Stancanelli, B; Cataliotti, A; Fatuzzo, P; Rapisarda, F; Bonanno, G; Bellanuova, I; Seminara, G; Leonardis, D; Tripepi, G.; Mallaci, F.; Zoccali, C. | file da validare |